IPP Bureau
Covestro and PharmaJet work to take the sting out of vaccinations
By IPP Bureau - April 07, 2022
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
MakGroup Healthcare becomes sole distributor of PixCell Medical's HemoScreen in the UAE
By IPP Bureau - April 07, 2022
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
Lupin completes acquisition of brands from Anglo-French
By IPP Bureau - April 07, 2022
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
JB Chemicals and Pharmaceuticals partners with Akshay Chaitanya to provide free lunch in hospitals
By IPP Bureau - April 07, 2022
Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai
Indian pharma growth likely to moderate in FY23: ICRA
By IPP Bureau - April 07, 2022
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
All India Institute of Ayurveda signs MoU with Safdarjung hospital
By IPP Bureau - April 07, 2022
The MoU sets down the guidelines for the establishment of an integrative medicine unit, joint research and academic activities in various fields of interest in Ayurveda and modern medicine
Alembic gets USFDA tentative approval for dabigatran etexilate capsules
By IPP Bureau - April 07, 2022
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
Lupin launches Merzee capsules in the United States
By IPP Bureau - April 07, 2022
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
CDMOs shifting focus to meet future demand
By IPP Bureau - April 07, 2022
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays
By IPP Bureau - April 07, 2022
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
By IPP Bureau - April 06, 2022
Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
Pristyn Care’s new app enables location-based discovery of doctors
By IPP Bureau - April 06, 2022
An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation
Hataali wins US patent for the use of blockchain in advanced medicinal therapy
By IPP Bureau - April 06, 2022
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
MilliporeSigma acquires MAST platform from Lonza
By IPP Bureau - April 06, 2022
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
BioFluidica to introduce next-generation biomarker isolation platform
By IPP Bureau - April 06, 2022
BioFluidica LiquidScan harnesses the power of microfluidics
